{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:31:26Z","timestamp":1775500286159,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T00:00:00Z","timestamp":1335571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>During periods of psychological stress, excess amounts of free radicals are produced. Bilirubin oxidative metabolites (biopyrrins; <jats:styled-content style=\"fixed-case\">BOM<\/jats:styled-content>) are generated from bilirubin as a result of its scavenging action against free radicals. We investigated whether the urinary excretion of biopyrrins is altered by anxiolytics. In the present study, mice were immobilized for a period of 6\u00a0hr. Alprazolam (0.1\u20131\u00a0mg\/kg of body\u2010weight) was administered 30\u00a0min. before subjecting the animals to acute stress. The <jats:styled-content style=\"fixed-case\">BOM<\/jats:styled-content> concentrations in urine and the corticosterone levels in serum were measured by <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content> with an anti\u2010bilirubin antibody and <jats:styled-content style=\"fixed-case\">EIA<\/jats:styled-content>, respectively. We observed an increase in urinary biopyrrins in stressed mice in comparison with non\u2010stressed mice and a decrease after the treatment of stressed animals with alprazolam. A correlation between urinary <jats:styled-content style=\"fixed-case\">BOM<\/jats:styled-content> and serum corticosterone levels was found. Urinary levels of biopyrrins might be used to assess the response to anxiolytics prescribed during acute stress periods.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2012.00888.x","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T14:35:27Z","timestamp":1333463727000},"page":"206-210","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary Biopyrrins: Potential Biomarker for Monitoring of the Response to Treatment with Anxiolytics"],"prefix":"10.1111","volume":"111","author":[{"given":"Silvia","family":"Nov\u00edo","sequence":"first","affiliation":[{"name":"Department of Nursing, School of Medicine and Nursing University of Santiago de Compostela A Coru\u00f1a Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Medicine and Nursing University of Santiago de Compostela A Coru\u00f1a Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Mar\u00eda","family":"Ponte","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine and Dentistry University of Santiago de Compostela A Coru\u00f1a Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Freire\u2010Garabal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine and Dentistry University of Santiago de Compostela A Coru\u00f1a Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.4161\/oxim.2.2.7944"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2010.08.007"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.33549\/physiolres.930807","article-title":"Alterations in hippocampal antioxidant enzyme activities and sympatho\u2010adrenomedullary system of rats in response to different stress models","volume":"55","author":"Pajovi\u0107 SB","year":"2006","journal-title":"Physiol Res"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.09-59"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.07.027"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02950-4"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3029864"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.00233.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1155\/1999\/16374"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0857"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/clinchem\/44.12.2554a","article-title":"Urine concentration of biopyrrins: a new marker for oxidative stress in vivo","volume":"44","author":"Shimoharada K","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00517-4"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2000.6036"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00233-4"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2131\/jts.28.71"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.11.002"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.08.098"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(93)90258-B"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2010.09.002"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2004.tb00003.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2007.12.003"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.31887\/DCNS.2011.13.2\/kwiedemann","article-title":"Biomarkers in development of psychotropic drugs","volume":"13","author":"Wiedemann K","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2006.04.009"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)00381-R"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1258\/002367799780578525"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0759-5-6"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2008.04.001"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-008-9118-1"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2005.06.012"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115856"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2006.05.018"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.12.039"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.06.028"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.05.001"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00199-3"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(02)00048-1"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-004-0484-3"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.11.009"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/00207450701769026"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a124523"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-004-0533-2"},{"key":"e_1_2_6_43_1","volume-title":"Antioxidant Methodology: In vivo and In Vitro Concepts","author":"Aruoma OI","year":"1997"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2012.00888.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2012.00888.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:22:02Z","timestamp":1698787322000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2012.00888.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,28]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1742-7843.2012.00888.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2012.00888.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,28]]},"assertion":[{"value":"2011-12-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}